EMA backs switch to biosimilars

22-09-2022

Muireann Bolger

EMA backs switch to biosimilars

Alessandro Zappalorto / Shutterstock.com

Evidence shows medicines approved as biosimilars in the EU may be prescribed interchangeably | Additional ‘switch’ studies no longer not need to be carried out.


Biosimilars, generic drug makers, medicines, Pinsent Masons

LSIPR